Emcure Pharmaceuticals Q1 FY26 performance was bolstered by healthy momentum across both domestic and international markets.
Read More
Think | Create | Scale
Most Commented News
Emcure Pharmaceuticals Q1 FY26 performance was bolstered by healthy momentum across both domestic and international markets.
Read More